Mar. 29, 2016, Valuentum Summary The integration of Covidien may steal the headlines in coming quarters, but all three of Medtronic’s legacy businesses are performing well. We’re watching the company’s growing financial leverage after taking on a significant amount of debt to facilitate the Covidien transaction. Its short and long-term borrowings have nearly tripled since 2013. […]